{
  "meta": {
    "title": "65_Non_Cell_Cycle_Specific_Cytotoxic_Drugs",
    "url": "https://brainandscalpel.vercel.app/65-non-cell-cycle-specific-cytotoxic-drugs-2412acbd.html",
    "scrapedAt": "2025-11-30T12:34:41.916Z"
  },
  "questions": [
    {
      "text": "Which of the following is more likely to be susceptible to alkylation with a bifunctional alkylating agent?",
      "choices": [
        {
          "id": 1,
          "text": "N3 of guanine"
        },
        {
          "id": 2,
          "text": "N1 of adenosine"
        },
        {
          "id": 3,
          "text": "N3 of adenosine"
        },
        {
          "id": 4,
          "text": "N7 of guanine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>N7 atom</strong> of <strong>guanine</strong> is particularly susceptible to&nbsp;alkylation with bifunctional alkylating agents. It leads to the formation of a <strong>covalent bond</strong> with bifunctional alkylating agents and represents the key target in nucleic acids for alkylating agents. Alkylation results in<strong> cross-linking/abnormal base pairing of DNA</strong> which inhibits DNA replication.</p>\n<p>Other sites that can be involved are:</p>\n<ul>\n<li>N1 and N3 of adenosine&nbsp;</li>\n<li>N3 of cytosine&nbsp;</li>\n<li>O6 of guanine&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4293",
      "difficulty": "medium"
    },
    {
      "text": "During a study on the cytotoxic effects of alkylating agents, you observe that cyclophosphamide has a higher cytotoxic effect compared to procarbazine. Which property of cyclophosphamide is the reason for this?",
      "choices": [
        {
          "id": 1,
          "text": "Cross-linking of DNA"
        },
        {
          "id": 2,
          "text": "Methylation of DNA"
        },
        {
          "id": 3,
          "text": "Additional inhibition of topoisomerase I"
        },
        {
          "id": 4,
          "text": "Additional inhibition of topoisomerase II"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Cyclophosphamide (nitrogen mustard) is a<strong> bifunctional alkylating agent</strong> and it results in <strong>cross-linking of DNA</strong> that causes a major disruption in nucleic acid function and increased <strong>cytotoxicity.</strong>&nbsp;</p>\n<p>Procarbazine is a monofunctional alkylating agent.</p>\n<p>Differences between bifunctional and monofunctional alkylating agents are:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Bifunctional alkylating agents</strong></p>\n</td>\n<td><strong>Monofunctional alkylating &nbsp;agents</strong></td>\n</tr>\n<tr>\n<td>Usually transfers ethyl group to DNA resulting in cross-linking</td>\n<td>Usually transfers a methyl group resulting in simple methylation. No cross-linking of DNA</td>\n</tr>\n<tr>\n<td>\n<p>Higher cytotoxicity because of cross-linking results in a greater threat to cellular survival</p>\n</td>\n<td>\n<p>Higher carcinogenesis risk as simple methylation can be bypassed by DNA polymerases resulting in permanent modification of DNA sequence</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4296",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following is not an alkylating agent?",
      "choices": [
        {
          "id": 1,
          "text": "Carmustine"
        },
        {
          "id": 2,
          "text": "Melphalan"
        },
        {
          "id": 3,
          "text": "Chlorambucil"
        },
        {
          "id": 4,
          "text": "5-Flourouracil"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>5-Flourouracil</strong> is a pyrimidine analogue and is an <strong>antimetabolite</strong>.</p><hr><h3>Related Pearl: Classification of antineoplastic drugs</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fd047e306bdc4310be749978ffaf0c5dx1280x1780.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp; &nbsp;Non-cell-cycle specific drugs</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alkylating agents</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nitrogen mustards</p>\n<ul>\n<li>Cyclophosphamide</li>\n<li>Ifosfamide</li>\n<li>Mechlorethamine</li>\n<li>Melphalan</li>\n<li>Chlorambucil</li>\n<li>Bendamustine</li>\n</ul>\n<p>Nitrosoureas</p>\n<ul>\n<li>Carmustine</li>\n<li>Lomustine</li>\n<li>Semustine</li>\n<li>Streptozocin</li>\n</ul>\n<p>Triazines (methylating agents)</p>\n<ul>\n<li>Procarbazine</li>\n<li>Dacarbazine</li>\n<li>Temozolomide</li>\n</ul>\n<p>Ethyleneimines</p>\n<ul>\n<li>Altretamine</li>\n<li>Thio-TEPA</li>\n</ul>\n<p>Alkyl sulfonates</p>\n<ul>\n<li>Busulfan</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Platinum compounds</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cisplatin</li>\n<li>Carboplatin</li>\n<li>Oxaliplatin&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anti-tumor antibiotics</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anthracyclines</p>\n<ul>\n<li>Doxorubicin (adriamycin)</li>\n<li>Daunorubicin (rubidomycin)</li>\n<li>Epirubicin</li>\n<li>Valrubicin</li>\n<li>Mitoxantrone</li>\n</ul>\n<p>Others</p>\n<ul>\n<li>Actinomycin-D (Dactinomycin)</li>\n<li>Mitomycin-C</li>\n<li>Bleomycin (also a G2-M phase inhibitor)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong> Cell-cycle specific drugs</strong></td>\n</tr>\n<tr>\n<td><strong>S-phase inhibitors</strong></td>\n</tr>\n<tr>\n<td><strong>Antimetabolites</strong></td>\n</tr>\n<tr>\n<td>Antifolate\n<ul>\n<li>Methotrexate</li>\n<li>Pemetrexed</li>\n<li>Pralatrexate</li>\n<li>Raltitrexed</li>\n</ul>\nPurine analogues\n<ul>\n<li>6-Mercaptopurine</li>\n<li>6-Thioguanine</li>\n<li>Fludarabine</li>\n<li>Cladribine</li>\n<li>Pentostatin</li>\n</ul>\nPyrimidine analogues\n<ul>\n<li>5-Fluorouracil</li>\n<li>Capecitabine</li>\n<li>Gemcitabine</li>\n<li>Cytarabine</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Topoisomerase inhibitors</strong></td>\n</tr>\n<tr>\n<td>Topoisomerase-1 inhibitors (ca)\n<ul>\n<li>Irinotecan</li>\n<li>Topotecan</li>\n</ul>\nTopoisomerase-2 inhibitors\n<ul>\n<li>Etoposide</li>\n<li>Teniposide</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Histone deacetylase inhibitors</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Vorinostat</li>\n<li>Belinostat</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Others </strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>&nbsp;Hydroxyurea</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>M-phase inhibitors (antimitotics or microtubule damaging agents)</strong></td>\n</tr>\n<tr>\n<td><strong>Vinca alkaloids</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Vincristine(Oncovin)</li>\n<li>Vinblastine</li>\n<li>Vinorelbine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Taxanes</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Paclitaxel</li>\n<li>Docetaxel</li>\n<li>Cabazitaxel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Others</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Epothilones</li>\n<li>Eribulin</li>\n<li>Estramustine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>G1-S phase inhibitor</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Epipodophyllotoxin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1142",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not a nitrogen mustard?",
      "choices": [
        {
          "id": 1,
          "text": "Mechlorethamine"
        },
        {
          "id": 2,
          "text": "Melphalan"
        },
        {
          "id": 3,
          "text": "Cyclophosphamide"
        },
        {
          "id": 4,
          "text": "Carmustine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Carmustine</strong> belongs to the <strong>nitrosourea</strong> class of alkylating agents.&nbsp;</p><hr><h3>Related Pearl: Classification of antineoplastic drugs</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fd047e306bdc4310be749978ffaf0c5dx1280x1780.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp; &nbsp;Non-cell-cycle specific drugs</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alkylating agents</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nitrogen mustards</p>\n<ul>\n<li>Cyclophosphamide</li>\n<li>Ifosfamide</li>\n<li>Mechlorethamine</li>\n<li>Melphalan</li>\n<li>Chlorambucil</li>\n<li>Bendamustine</li>\n</ul>\n<p>Nitrosoureas</p>\n<ul>\n<li>Carmustine</li>\n<li>Lomustine</li>\n<li>Semustine</li>\n<li>Streptozocin</li>\n</ul>\n<p>Triazines (methylating agents)</p>\n<ul>\n<li>Procarbazine</li>\n<li>Dacarbazine</li>\n<li>Temozolomide</li>\n</ul>\n<p>Ethyleneimines</p>\n<ul>\n<li>Altretamine</li>\n<li>Thio-TEPA</li>\n</ul>\n<p>Alkyl sulfonates</p>\n<ul>\n<li>Busulfan</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Platinum compounds</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cisplatin</li>\n<li>Carboplatin</li>\n<li>Oxaliplatin&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anti-tumor antibiotics</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anthracyclines</p>\n<ul>\n<li>Doxorubicin (adriamycin)</li>\n<li>Daunorubicin (rubidomycin)</li>\n<li>Epirubicin</li>\n<li>Valrubicin</li>\n<li>Mitoxantrone</li>\n</ul>\n<p>Others</p>\n<ul>\n<li>Actinomycin-D (Dactinomycin)</li>\n<li>Mitomycin-C</li>\n<li>Bleomycin (also a G2-M phase inhibitor)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong> Cell-cycle specific drugs</strong></td>\n</tr>\n<tr>\n<td><strong>S-phase inhibitors</strong></td>\n</tr>\n<tr>\n<td><strong>Antimetabolites</strong></td>\n</tr>\n<tr>\n<td>Antifolate\n<ul>\n<li>Methotrexate</li>\n<li>Pemetrexed</li>\n<li>Pralatrexate</li>\n<li>Raltitrexed</li>\n</ul>\nPurine analogues\n<ul>\n<li>6-Mercaptopurine</li>\n<li>6-Thioguanine</li>\n<li>Fludarabine</li>\n<li>Cladribine</li>\n<li>Pentostatin</li>\n</ul>\nPyrimidine analogues\n<ul>\n<li>5-Fluorouracil</li>\n<li>Capecitabine</li>\n<li>Gemcitabine</li>\n<li>Cytarabine</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Topoisomerase inhibitors</strong></td>\n</tr>\n<tr>\n<td>Topoisomerase-1 inhibitors (ca)\n<ul>\n<li>Irinotecan</li>\n<li>Topotecan</li>\n</ul>\nTopoisomerase-2 inhibitors\n<ul>\n<li>Etoposide</li>\n<li>Teniposide</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Histone deacetylase inhibitors</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Vorinostat</li>\n<li>Belinostat</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Others </strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>&nbsp;Hydroxyurea</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>M-phase inhibitors (antimitotics or microtubule damaging agents)</strong></td>\n</tr>\n<tr>\n<td><strong>Vinca alkaloids</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Vincristine(Oncovin)</li>\n<li>Vinblastine</li>\n<li>Vinorelbine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Taxanes</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Paclitaxel</li>\n<li>Docetaxel</li>\n<li>Cabazitaxel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Others</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Epothilones</li>\n<li>Eribulin</li>\n<li>Estramustine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>G1-S phase inhibitor</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Epipodophyllotoxin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4294",
      "difficulty": "medium"
    },
    {
      "text": "Temozolomide is used as a first-line agent for the management of which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Anaplastic astrocytoma"
        },
        {
          "id": 2,
          "text": "Glioblastoma multiforme"
        },
        {
          "id": 3,
          "text": "Acoustic neuroma"
        },
        {
          "id": 4,
          "text": "Craniopharyngioma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Temozolomide</strong> is used as a first-line agent for the management of <strong>glioblastoma multiforme</strong>. It is used for&nbsp;newly diagnosed cases along with radiotherapy and also used for maintenance therapy.</p>\n<p>Temozolomide belongs to the triazene group of alkylating agents and is administered orally. The oral bioavailability of temozolomide is nearly 100%.</p>\n<p>In anaplastic astrocytoma, refractory cases with disease progression are treated with a regimen containing nitrosourea and procarbazine.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1147",
      "difficulty": "medium"
    },
    {
      "text": "A patient is diagnosed with astrocytoma. Which of the following drugs crosses the blood brain barrier and hence can be used for the treatment of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Cisplatin"
        },
        {
          "id": 2,
          "text": "Lomustine"
        },
        {
          "id": 3,
          "text": "Vincristine"
        },
        {
          "id": 4,
          "text": "Vinblastine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Lomustine</strong> can cross the blood-brain barrier and is used in the management of brain tumours like astrocytoma.</p>\n<p><strong>Nitrosoureas</strong> like lomustine and carmustine are&nbsp;<strong>highly lipophilic</strong>&nbsp;drugs and can easily<strong> cross the blood-brain barrier.</strong>&nbsp;Hence, they are indicated in the management of brain tumors.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1148",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs is not an anthracycline antibiotic?",
      "choices": [
        {
          "id": 1,
          "text": "Doxorubicin"
        },
        {
          "id": 2,
          "text": "Dactinomycin"
        },
        {
          "id": 3,
          "text": "Mitoxantrone"
        },
        {
          "id": 4,
          "text": "Epirubicin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Dactinomycin or actinomycin D is an <strong>actinomycin</strong> and not an anthracycline antibiotic.</p><hr><h3>Related Pearl: Classification of antineoplastic drugs</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fd047e306bdc4310be749978ffaf0c5dx1280x1780.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp; &nbsp;Non-cell-cycle specific drugs</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alkylating agents</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nitrogen mustards</p>\n<ul>\n<li>Cyclophosphamide</li>\n<li>Ifosfamide</li>\n<li>Mechlorethamine</li>\n<li>Melphalan</li>\n<li>Chlorambucil</li>\n<li>Bendamustine</li>\n</ul>\n<p>Nitrosoureas</p>\n<ul>\n<li>Carmustine</li>\n<li>Lomustine</li>\n<li>Semustine</li>\n<li>Streptozocin</li>\n</ul>\n<p>Triazines (methylating agents)</p>\n<ul>\n<li>Procarbazine</li>\n<li>Dacarbazine</li>\n<li>Temozolomide</li>\n</ul>\n<p>Ethyleneimines</p>\n<ul>\n<li>Altretamine</li>\n<li>Thio-TEPA</li>\n</ul>\n<p>Alkyl sulfonates</p>\n<ul>\n<li>Busulfan</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Platinum compounds</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cisplatin</li>\n<li>Carboplatin</li>\n<li>Oxaliplatin&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anti-tumor antibiotics</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anthracyclines</p>\n<ul>\n<li>Doxorubicin (adriamycin)</li>\n<li>Daunorubicin (rubidomycin)</li>\n<li>Epirubicin</li>\n<li>Valrubicin</li>\n<li>Mitoxantrone</li>\n</ul>\n<p>Others</p>\n<ul>\n<li>Actinomycin-D (Dactinomycin)</li>\n<li>Mitomycin-C</li>\n<li>Bleomycin (also a G2-M phase inhibitor)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong> Cell-cycle specific drugs</strong></td>\n</tr>\n<tr>\n<td><strong>S-phase inhibitors</strong></td>\n</tr>\n<tr>\n<td><strong>Antimetabolites</strong></td>\n</tr>\n<tr>\n<td>Antifolate\n<ul>\n<li>Methotrexate</li>\n<li>Pemetrexed</li>\n<li>Pralatrexate</li>\n<li>Raltitrexed</li>\n</ul>\nPurine analogues\n<ul>\n<li>6-Mercaptopurine</li>\n<li>6-Thioguanine</li>\n<li>Fludarabine</li>\n<li>Cladribine</li>\n<li>Pentostatin</li>\n</ul>\nPyrimidine analogues\n<ul>\n<li>5-Fluorouracil</li>\n<li>Capecitabine</li>\n<li>Gemcitabine</li>\n<li>Cytarabine</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Topoisomerase inhibitors</strong></td>\n</tr>\n<tr>\n<td>Topoisomerase-1 inhibitors (ca)\n<ul>\n<li>Irinotecan</li>\n<li>Topotecan</li>\n</ul>\nTopoisomerase-2 inhibitors\n<ul>\n<li>Etoposide</li>\n<li>Teniposide</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Histone deacetylase inhibitors</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Vorinostat</li>\n<li>Belinostat</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Others </strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>&nbsp;Hydroxyurea</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>M-phase inhibitors (antimitotics or microtubule damaging agents)</strong></td>\n</tr>\n<tr>\n<td><strong>Vinca alkaloids</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Vincristine(Oncovin)</li>\n<li>Vinblastine</li>\n<li>Vinorelbine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Taxanes</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Paclitaxel</li>\n<li>Docetaxel</li>\n<li>Cabazitaxel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Others</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Epothilones</li>\n<li>Eribulin</li>\n<li>Estramustine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>G1-S phase inhibitor</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Epipodophyllotoxin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1178",
      "difficulty": "medium"
    },
    {
      "text": "Topical mitomycin C is used in which of the following patients?",
      "choices": [
        {
          "id": 1,
          "text": "A patient with Sturge-Weber syndrome"
        },
        {
          "id": 2,
          "text": "A patient with laryngotracheal stenosis"
        },
        {
          "id": 3,
          "text": "A patient undergoing endoscopic treatment of angiofibroma"
        },
        {
          "id": 4,
          "text": "A patient with hand-foot syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Topical mitomycin C is used in <strong>laryngotracheal stenosis</strong>.</p>\n<p>Mitomycin C is an antitumor antibiotic that inhibits cell division, protein synthesis and fibroblast proliferation. Topical mitomycin C has been shown to cause symptomatic improvement when applied to patients with laryngotracheal stenosis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1161",
      "difficulty": "easy"
    },
    {
      "text": "A patient with superficial bladder carcinoma is being treated with a drug by intravesical therapy. Identify this drug.",
      "choices": [
        {
          "id": 1,
          "text": "Actinomycin"
        },
        {
          "id": 2,
          "text": "Mitomycin"
        },
        {
          "id": 3,
          "text": "Cisplatin"
        },
        {
          "id": 4,
          "text": "Vincristine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Mitomycin C</strong> is used in the treatment of superficial transitional cell carcinoma by intravesical instillation. It is also used in upper gastrointestinal cancers (e.g. esophageal carcinoma), anal cancers, and breast cancers.</p>\n<p>Topical mitomycin C is used in:</p>\n<ul>\n<li>Superficial bladder cancer</li>\n<li>Intraperitoneal tumors</li>\n<li>Strabismus surgery to reduce scarring</li>\n<li>To prevent tracheal and esophageal stenosis</li>\n<li>Post nasal surgery synechae formation</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1162",
      "difficulty": "medium"
    },
    {
      "text": "A patient was diagnosed with acute promyelocytic leukemia and chemotherapy was initiated. The patient achieved complete remission. However, after a few months molecular relapse was detected. Which of the following drugs would be highly effective in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Tretinoin"
        },
        {
          "id": 2,
          "text": "Arsenic trioxide"
        },
        {
          "id": 3,
          "text": "Idarubicin"
        },
        {
          "id": 4,
          "text": "Cytarabine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Arsenic trioxide</strong> (ATO) is highly effective in <strong>relapsed or refractory</strong> acute promyelocytic leukemia (APL). It acts by enhancing reactive oxygen free radical generation in APL cells.</p>\n<p>Tretinoin and idarubicin (anthracycline) are usually first-line agents for acute promyelocytic leukemia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1183",
      "difficulty": "medium"
    },
    {
      "text": "A patient with osteosarcoma was initiated on chemotherapy. After a few days, he developed dysuria and hematuria. Which group of drugs among the following is most likely to have caused this complication?",
      "choices": [
        {
          "id": 1,
          "text": "Alkylating agents"
        },
        {
          "id": 2,
          "text": "Antimetabolites"
        },
        {
          "id": 3,
          "text": "Mitotic inhibitors"
        },
        {
          "id": 4,
          "text": "Topoisomerase inhibitors"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>This scenario depicts haemorrhagic cystitis and the possible cause could be <strong>alkylating agents</strong> like <strong>ifosfamide</strong>.&nbsp;</p>\n<p>Chemotherapeutic agents used for the treatment of osteosarcoma include ifosfamide, which is one of the commonest drugs causing haemorrhagic cystitis.</p>\n<p>Ifosfamide is a nitrogen mustard and belongs to the alkylating agents.&nbsp;</p><hr><h3>Related Pearl: Classification of antineoplastic drugs</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fd047e306bdc4310be749978ffaf0c5dx1280x1780.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp; &nbsp;Non-cell-cycle specific drugs</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alkylating agents</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nitrogen mustards</p>\n<ul>\n<li>Cyclophosphamide</li>\n<li>Ifosfamide</li>\n<li>Mechlorethamine</li>\n<li>Melphalan</li>\n<li>Chlorambucil</li>\n<li>Bendamustine</li>\n</ul>\n<p>Nitrosoureas</p>\n<ul>\n<li>Carmustine</li>\n<li>Lomustine</li>\n<li>Semustine</li>\n<li>Streptozocin</li>\n</ul>\n<p>Triazines (methylating agents)</p>\n<ul>\n<li>Procarbazine</li>\n<li>Dacarbazine</li>\n<li>Temozolomide</li>\n</ul>\n<p>Ethyleneimines</p>\n<ul>\n<li>Altretamine</li>\n<li>Thio-TEPA</li>\n</ul>\n<p>Alkyl sulfonates</p>\n<ul>\n<li>Busulfan</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Platinum compounds</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cisplatin</li>\n<li>Carboplatin</li>\n<li>Oxaliplatin&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anti-tumor antibiotics</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anthracyclines</p>\n<ul>\n<li>Doxorubicin (adriamycin)</li>\n<li>Daunorubicin (rubidomycin)</li>\n<li>Epirubicin</li>\n<li>Valrubicin</li>\n<li>Mitoxantrone</li>\n</ul>\n<p>Others</p>\n<ul>\n<li>Actinomycin-D (Dactinomycin)</li>\n<li>Mitomycin-C</li>\n<li>Bleomycin (also a G2-M phase inhibitor)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong> Cell-cycle specific drugs</strong></td>\n</tr>\n<tr>\n<td><strong>S-phase inhibitors</strong></td>\n</tr>\n<tr>\n<td><strong>Antimetabolites</strong></td>\n</tr>\n<tr>\n<td>Antifolate\n<ul>\n<li>Methotrexate</li>\n<li>Pemetrexed</li>\n<li>Pralatrexate</li>\n<li>Raltitrexed</li>\n</ul>\nPurine analogues\n<ul>\n<li>6-Mercaptopurine</li>\n<li>6-Thioguanine</li>\n<li>Fludarabine</li>\n<li>Cladribine</li>\n<li>Pentostatin</li>\n</ul>\nPyrimidine analogues\n<ul>\n<li>5-Fluorouracil</li>\n<li>Capecitabine</li>\n<li>Gemcitabine</li>\n<li>Cytarabine</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Topoisomerase inhibitors</strong></td>\n</tr>\n<tr>\n<td>Topoisomerase-1 inhibitors (ca)\n<ul>\n<li>Irinotecan</li>\n<li>Topotecan</li>\n</ul>\nTopoisomerase-2 inhibitors\n<ul>\n<li>Etoposide</li>\n<li>Teniposide</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Histone deacetylase inhibitors</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Vorinostat</li>\n<li>Belinostat</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Others </strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>&nbsp;Hydroxyurea</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>M-phase inhibitors (antimitotics or microtubule damaging agents)</strong></td>\n</tr>\n<tr>\n<td><strong>Vinca alkaloids</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Vincristine(Oncovin)</li>\n<li>Vinblastine</li>\n<li>Vinorelbine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Taxanes</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Paclitaxel</li>\n<li>Docetaxel</li>\n<li>Cabazitaxel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Others</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Epothilones</li>\n<li>Eribulin</li>\n<li>Estramustine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>G1-S phase inhibitor</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Epipodophyllotoxin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1218",
      "difficulty": "easy"
    },
    {
      "text": "Hemorrhagic cystitis is a characteristic side effect of which of the following drugs?",
      "choices": [
        {
          "id": 1,
          "text": "Melphalan"
        },
        {
          "id": 2,
          "text": "Busalfan"
        },
        {
          "id": 3,
          "text": "Cyclophosphamide"
        },
        {
          "id": 4,
          "text": "Procarbazine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Hemorrhagic cystitis is a characteristic side effect of <strong>cyclophosphamide</strong>.&nbsp;The metabolite responsible for hemorrhagic cystitis is <strong>acrolein</strong>. This can be decreased by vigorous hydration and by the use of <strong>mercapto ethane sulfonic acid (mesna).</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1143",
      "difficulty": "easy"
    },
    {
      "text": "A 62-year-old woman with breast carcinoma is started on cyclophosphamide. What is the rationale behind using sodium 2-mercaptoethanesulfonate along with this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Increase absorption"
        },
        {
          "id": 2,
          "text": "Decrease excretion"
        },
        {
          "id": 3,
          "text": "Ameliorate hemorrhagic cystitis"
        },
        {
          "id": 4,
          "text": "Decrease metabolism"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Sodium 2-mercaptoethanesulfonate (MESNA) is given along with cyclophosphamide to <strong>reduce</strong> the incidence of <strong>hemorrhagic cystitis</strong>. &nbsp; &nbsp;</p>\n<p>MESNA concentrates in the bladder where acrolein accumulates after administration of cyclophosphamide and ifosfamide. It&nbsp;forms a conjugate with acrolein and other urotoxic metabolites.&nbsp;<sup id=\"cite_ref-Thurston_2007_7-1\" class=\"reference\"></sup>This conjugation reaction inactivates the urotoxic compounds to harmless metabolites which are excreted in the urine.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1144",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements about ifosfamide is false?",
      "choices": [
        {
          "id": 1,
          "text": "Metabolised by cytochrome P450 enzymes"
        },
        {
          "id": 2,
          "text": "Less neurotoxic than cyclophosphamide"
        },
        {
          "id": 3,
          "text": "Chloroacetaldehyde is the metabolite of ifosfamide"
        },
        {
          "id": 4,
          "text": "It is a nitrogen mustard"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Ifosfamide</strong> is <strong>more neurotoxic</strong> than cyclophosphamide. It causes greater platelet suppression, nephrotoxicity, and urothelial damage when compared to cyclophosphamide.</p>\n<p>Ifosfamide is a nitrogen mustard (alkylating agent). It is metabolized by hydroxylation by cytochrome P450 enzymes. Chloroacetaldehyde is a metabolite of ifosfamide that is responsible for severe neurological adverse effects.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1146",
      "difficulty": "medium"
    },
    {
      "text": "A 67 year old woman with a malignant lump in the breast who is undergoing chemotherapy, presents with shortness of breath, tachycardia and hypertension. ECG shows ST and T wave changes. Which among the following drugs could have led to this?",
      "choices": [
        {
          "id": 1,
          "text": "Doxorubicin"
        },
        {
          "id": 2,
          "text": "Mitomycin-C"
        },
        {
          "id": 3,
          "text": "Bleomycin"
        },
        {
          "id": 4,
          "text": "Actinomycin-D"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>This scenario depicts Doxorubicin induced <strong>cardiotoxicity</strong>. It is a unique adverse effect of <strong>doxorubicin</strong>. It is an anthracycline group of anticancer antibiotics.</p>\n<p>Doxorubicin-induced cardiomyopathy takes two forms:</p>\n<ul>\n<li><strong>Acute:</strong>&nbsp;pericarditis-myocarditis syndrome,&nbsp;arrhythmias, ST and T wave changes in ECG.</li>\n<li><strong>Chronic:</strong> dilated cardiomyopathy.</li>\n</ul>\n<p>Note:<strong>&nbsp;Dexrazoxane</strong> is a cardioprotective iron-chelating agent that is indicated for use along with high dose doxorubicin to avoid cardiotoxicity.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1185",
      "difficulty": "easy"
    },
    {
      "text": "A 54-year-old man is diagnosed with Kaposi sarcoma. You are planning to start chemotherapy with doxorubicin, which can cause cardiotoxicity. Which of the following drugs would you prescribe to prevent this?",
      "choices": [
        {
          "id": 1,
          "text": "Leucovorin"
        },
        {
          "id": 2,
          "text": "Mesna"
        },
        {
          "id": 3,
          "text": "Dexrazoxane"
        },
        {
          "id": 4,
          "text": "Dexamethasone"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Dexrazoxane</strong> is a <strong>cardioprotective</strong> iron-chelating agent that is indicated for use along with high dose doxorubicin to avoid cardiotoxicity. The exact cardioprotective mechanism of dexrazoxane is unknown and it appears not to compromise with anticancer activity of doxorubicin.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1187",
      "difficulty": "easy"
    },
    {
      "text": "Least cardiotoxicity is seen with which of the following anthracycline antibiotic?",
      "choices": [
        {
          "id": 1,
          "text": "Doxorubicin"
        },
        {
          "id": 2,
          "text": "Daunorubicin"
        },
        {
          "id": 3,
          "text": "Idarubicin"
        },
        {
          "id": 4,
          "text": "Epirubicin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Idarubicin</strong> has <strong>least cardiotoxicity</strong> when compared to other anthracyclines.</p>\n<p>It is approved for use in <strong>acute myeloid leukemia</strong> along with cytarabine.&nbsp;Doxorubicin, daunorubicin and epirubicin share similar cardiotoxicity profile.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1189",
      "difficulty": "medium"
    },
    {
      "text": "While reviewing the drug chart of a patient undergoing radiotherapy, which of the following drugs would require a dose adjustment to prevent radiation toxicity?",
      "choices": [
        {
          "id": 1,
          "text": "Vincristine"
        },
        {
          "id": 2,
          "text": "Doxorubicin"
        },
        {
          "id": 3,
          "text": "Cyclophosphamide"
        },
        {
          "id": 4,
          "text": "6-mercaptopurine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Doxorubicin</strong> requires <strong>dose adjustment</strong> during or after radiotherapy in order to <strong>prevent radiation toxicity.</strong></p>\n<p>Anthracyclines like doxorubicin&nbsp;can result in a <strong>radiation recall reaction,</strong>&nbsp;where erythema and desquamation of skin are observed at sites of previous radiation injury.&nbsp;The risk of <strong>cardiotoxicity</strong> also increases with previous irradiation.&nbsp;Therefore, careful monitoring and dosage adjustments are required for doxorubicin.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1215",
      "difficulty": "medium"
    },
    {
      "text": "A patient is undergoing chemotherapy for glioblastoma multiforme. You notice that his serial blood investigations reveal sustained neutropenia. Which of the following drugs could have caused this?",
      "choices": [
        {
          "id": 1,
          "text": "Carmustine"
        },
        {
          "id": 2,
          "text": "Cisplatin"
        },
        {
          "id": 3,
          "text": "Vinblastine"
        },
        {
          "id": 4,
          "text": "Cyclophosphamide"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Sustained neutropenia is seen&nbsp;with <strong>nitrosoureas</strong>. Nitrosoureas like <strong>carmustine</strong> and <strong>lomustine</strong> cause profound and delayed<strong> myelosuppression </strong>with recovery 4-6 weeks after a single dose.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1210",
      "difficulty": "medium"
    },
    {
      "text": "A patient with Hodgkin’s disease on chemotherapy with an alkylating agent develops behavioral disturbances and experiences sedation. He presented to the emergency room with a disulfiram-like reaction. What is the drug being described here?",
      "choices": [
        {
          "id": 1,
          "text": "Dacarbazine"
        },
        {
          "id": 2,
          "text": "Procarbazine"
        },
        {
          "id": 3,
          "text": "Carmustine"
        },
        {
          "id": 4,
          "text": "Lomustine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The most likely alkylating agent being described here is <strong>procarbazine</strong>. It is associated with behavioural disturbances and sedation. Concomitant CNS depressants should be avoided.</p>\n<p>Procarbazine is a<strong> weak MAO inhibitor</strong> and can potentiate tyramine and catecholamines action. It also has<strong> disulfiram-like actions</strong> and alcohol should be avoided. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4298",
      "difficulty": "medium"
    },
    {
      "text": "A 50 year old man who presented with dysphagia was diagnosed with esophageal carcinoma and underwent multiple cycles of chemotherapy. During the cycles, he had developed tingling and numbness in the lower limbs and the symptoms progressed even after cessation of the cycles. Which drug could have led to this?",
      "choices": [
        {
          "id": 1,
          "text": "Cisplatin"
        },
        {
          "id": 2,
          "text": "Paclitaxel"
        },
        {
          "id": 3,
          "text": "Mitomycin"
        },
        {
          "id": 4,
          "text": "Vincristine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The scenario depicts <strong>coasting effect neuropathy</strong>, which is seen with <strong>cisplatin</strong>.</p>\n<p>The coasting effect means the progression of <strong>symptoms</strong> even <strong>after</strong> the <strong>cessation</strong> of the drug. <strong>Neurotoxicity</strong> is usually dependent on the cumulative dose of anticancer drugs. The severity of neuropathy increases with the duration of treatment and progression stops once drug treatment is completed.&nbsp;</p>\n<p><strong>Platinum compounds</strong> are an exception, where <strong>sensory loss progresses</strong> for several months <strong>after cessation of treatment</strong>. The coasting effect is more common with cisplatin and oxaliplatin than with carboplatin.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1209",
      "difficulty": "medium"
    },
    {
      "text": "A 65 year old man who was diagnosed with small cell carcinoma of the lung had undergone chemotherapy about 5 years ago. Now he presents with features suggestive of AML. Which of the following drugs could have caused this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Vinblastine"
        },
        {
          "id": 2,
          "text": "Paclitaxel"
        },
        {
          "id": 3,
          "text": "Cisplatin"
        },
        {
          "id": 4,
          "text": "Bleomycin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The scenario is suggestive of&nbsp;<strong>secondary leukemia</strong> which is associated with <strong>c</strong><strong>isplatin</strong>. Cisplatin is a platinum-containing anticancer agent that forms DNA adduct. It is associated with the development of AML usually more than 4 years after treatment.</p>\n<p>Procarbazine, a methylhydralazine (alkylating agent), is most commonly associated with the development of leukemias with a 5-10% risk of acute leukemia in patients treated with the MOPP regimen.</p>\n<p>Cisplatin produces responses in cancers of the bladder, head and neck, cervix, and endometrium; all forms of carcinoma of the lung; anal and rectal carcinomas; and neoplasms of childhood.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1212",
      "difficulty": "medium"
    },
    {
      "text": "A patient who was diagnosed with gastric carcinoma is undergoing chemotherapy. His serum creatinine levels are rising and you suspect renal tubular damage caused by one of his chemotherapeutic drugs. Which drug could it be?",
      "choices": [
        {
          "id": 1,
          "text": "Cisplatin"
        },
        {
          "id": 2,
          "text": "Streptozocin"
        },
        {
          "id": 3,
          "text": "Methysergide"
        },
        {
          "id": 4,
          "text": "Cyclophosphamide"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given scenario is suggesstive of <strong>nephrotoxicity</strong> and it is one of the dose-limiting toxicity of <strong>cisplatin</strong> therapy. Cisplatin achieves a high concentration in nephrons. Both direct toxicity and inflammation are responsible for nephrotoxicity.&nbsp;A high concentration of chloride stabilizes cisplatin and reduces nephrotoxicity. Therefore,<strong> chloride diuresis</strong> is used to reduce nephrotoxicity.</p>\n<p>Option B - Streptozotocin use can result in diabetes mellitus due to the destruction of beta cells of the pancreas.</p>\n<p>Option C - Methysergide use is associated with retroperitoneal fibrosis.</p>\n<p>Option D - Cyclophosphamide causes hemorrhagic cystitis as one of its characteristic side effect.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1213",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following is a highly emetogenic anticancer drug?",
      "choices": [
        {
          "id": 1,
          "text": "Paclitaxel"
        },
        {
          "id": 2,
          "text": "Vincristine"
        },
        {
          "id": 3,
          "text": "Cisplatin"
        },
        {
          "id": 4,
          "text": "5-Fluorouracil"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Cisplatin</strong> is a highly emetogenic anticancer drug.&nbsp;Cisplatin causes marked nausea and vomiting in almost all cases and is usually administered along with anti-emetic regimens.</p>\n<p>This can usually be controlled with 5HT3 receptor antagonists, neurokinin (NK1) receptor antagonists (e.g., aprepitant), and high-dose corticosteroids.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1165",
      "difficulty": "easy"
    },
    {
      "text": "A patient who is undergoing chemotherapy for testicular cancer, now presents with dyspnea and dry cough. Investigations suggest pulmonary fibrosis. This condition is commonly  associated with which of the following drugs?",
      "choices": [
        {
          "id": 1,
          "text": "Bleomycin"
        },
        {
          "id": 2,
          "text": "Cisplatin"
        },
        {
          "id": 3,
          "text": "Methotrexate"
        },
        {
          "id": 4,
          "text": "Actinomycin D"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Pulmonary fibrosis</strong> is commonly seen with <strong>bleomycin</strong>.&nbsp;The main abnormality in bleomycin toxicity occurs in endothelial and epithelial cells.&nbsp;This leads to the <strong>destruction</strong> and desquamation of<strong> type I pneumocytes</strong>&nbsp;and the resultant <strong>hyperplasia</strong> of <strong>type II pneumocytes.&nbsp;</strong></p>\n<p>Pulmonary toxicity begins with a dry cough, fine rales, and diffuse basal infiltrates on X-ray and may progress to life-threatening pulmonary fibrosis.&nbsp;No specific treatment is available to ameliorate the toxicity and managed by general symptomatic care.</p><p>Note: Few case reports of methotrexate causing pulmonary fibrosis are reported. The association is still uncertain as the underlying disease process like RA can also contribute to fibrosis.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1196",
      "difficulty": "easy"
    },
    {
      "text": "A patient who is undergoing chemotherapy, now presents with weight gain, ascites, hepatomegaly and hyperbilirubinemia. You suspect sinusoidal obstruction syndrome. Which drug is the most common cause of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Ifosfamide"
        },
        {
          "id": 2,
          "text": "Cyclophosphamide"
        },
        {
          "id": 3,
          "text": "Bleomycin"
        },
        {
          "id": 4,
          "text": "Busulfan"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Sinusoidal obstruction syndrome&nbsp;</strong>is most commonly associated with <strong>high-dose busulfan</strong>.&nbsp;Incidence increases when coadministered with CYP inhibitors.</p>\n<p>Sinusoidal obstruction syndrome, previously known as veno-occlusive hepatic disease (VOD), involves primary hepatic sinusoidal injury that progresses to diffuse hepatocyte involvement and panvasculitis. This leads to multi-organ failure, and can be life-threatening.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1150",
      "difficulty": "medium"
    },
    {
      "text": "A patient undergoing chemotherapy was brought to the ER with seizures. He is diagnosed with cerebrovascular accident which you suspect to be due to a drug-induced hypercoagulable state. Which of the following drugs is implicated?",
      "choices": [
        {
          "id": 1,
          "text": "5-FU"
        },
        {
          "id": 2,
          "text": "L-asparaginase"
        },
        {
          "id": 3,
          "text": "Melphalan"
        },
        {
          "id": 4,
          "text": "Carmustine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>L-asparaginase</strong> causes a <strong>hypercoagulable state</strong>. It is an enzyme and toxicity results due to the inhibition of protein synthesis in normal tissues.</p>\n<p>Side effects of&nbsp;L-asparaginase:</p>\n<ul>\n<li>Thrombosis and increased coagulation - physiological anticlotting factors are impaired</li>\n<li>Hemorrhage and bleeding - clotting factors are impaired</li>\n<li>Hyperglycemia - insulin deficiency.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1194",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs causes flagellate pigmentation?",
      "choices": [
        {
          "id": 1,
          "text": "Bleomycin"
        },
        {
          "id": 2,
          "text": "Doxorubicin"
        },
        {
          "id": 3,
          "text": "Vincristine"
        },
        {
          "id": 4,
          "text": "Minocycline"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><span class=\"TextRun SCXW81824019\" lang=\"EN-US\" xml:lang=\"EN-US\"><span class=\"NormalTextRun SCXW81824019\"><strong>Flagellate hyperpigmentation/flagellate erythema</strong>&nbsp;</span></span><span class=\"TextRun SCXW81824019\" lang=\"EN-US\" xml:lang=\"EN-US\"><span class=\"NormalTextRun SCXW81824019\">is</span></span><span class=\"TextRun SCXW81824019\" lang=\"EN-US\" xml:lang=\"EN-US\"><span class=\"NormalTextRun SCXW81824019\">&nbsp;a characteristic cutaneous reaction to treatment with <strong>b</strong></span></span><strong><span class=\"TextRun Underlined SCXW81824019\" lang=\"EN-US\" xml:lang=\"EN-US\"><span class=\"NormalTextRun SCXW81824019\">leomycin</span></span></strong><span class=\"TextRun SCXW81824019\" lang=\"EN-US\" xml:lang=\"EN-US\"><span class=\"NormalTextRun SCXW81824019\">.&nbsp;</span></span></p>\n<p><span class=\"TextRun SCXW81824019\" lang=\"EN-US\" xml:lang=\"EN-US\"><span class=\"NormalTextRun SCXW81824019\">Clinical features include <strong>multiple linear streaks</strong> (erythematous or hyperpigmented) <strong>at sites of trauma and generalized pruritus</strong>.</span></span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/378bdd93332c47f1ac9b787f8fc79dccx512x140.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3490",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following drugs cause carcinoma bladder?",
      "choices": [
        {
          "id": 1,
          "text": "Cyclophosphamide"
        },
        {
          "id": 2,
          "text": "Cisplatin"
        },
        {
          "id": 3,
          "text": "Taxane"
        },
        {
          "id": 4,
          "text": "Tamoxifen"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The only chemotherapeutic agent that has been proven to cause bladder cancer is <strong>cyclophosphamide</strong>.</p>\n<p>The risk of the bladder cancer formation is linearly related to the duration and intensity of cyclophosphamide treatment, supporting a causative role. <strong>Phosphoramide mustard</strong> is the primary <strong>mutagenic metabolite</strong> that causes bladder cancer in patients exposed to cyclophosphamide.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD1295",
      "difficulty": "easy"
    }
  ]
}